As of 2025-07-04, the Fair Value of Cure Pharmaceutical Holding Corp (CURR) is -7.43 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.04 USD, the upside of Cure Pharmaceutical Holding Corp is -814.16%.
With the market price of 1.04 USD and our fair value calculation, Cure Pharmaceutical Holding Corp (CURR) is not a good investment. Investing in CURR stocks now will result in a potential loss of 814.16%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -0.18 | -1.11 | 3.15 | -39.48 | -12.48 | |
| YoY growth | -% | -516.67% | 383.56% | -1,354.18% | -495.76% | |
| Market Cap (mil) | 20.17 |
| P/E | |
| Forward P/E |
| EPS | -1.49 |
| Avg earnings growth rate | -495.76% |
| TTM earnings | -37.13 |